A single dose of the Pfizer-BioNTech vaccine for people who have already had COVID-19 generates an immunologic response similar to that in people who receive the two-dose recommended sequence, according to a study released Thursday by researchers at Cedars-Sinai. The study suggests that the second dose may not be needed for people who have successfully […]